# Vascular Effects of Sitagliptin in Diabetes Mellitus

> **NCT01096277** · PHASE4 · UNKNOWN · sponsor: **Hannover Medical School** · enrollment: 70 (estimated)

## Conditions studied

- Type 2 Diabetes Mellitus

## Interventions

- **DRUG:** Sitagliptin
- **DRUG:** Placebo
- **OTHER:** Control

## Key facts

- **NCT ID:** NCT01096277
- **Lead sponsor:** Hannover Medical School
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-10
- **Primary completion:** 2011-11
- **Final completion:** 2012-12
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2010-03-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01096277

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01096277, "Vascular Effects of Sitagliptin in Diabetes Mellitus". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01096277. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*